September 13, 2012
Cryoport and Kryosphere Form Strategic Marketing Alliance
Cryoport, Inc. (CYRX) today announced it has formed a strategic partnership with Kryosphere, a leading biorepository serving clients throughout North America and internationally. Cryoport and Kryosphere will introduce each other’s capabilities and expertise in Cold Chain Logistics and Management of biomaterials to their customers with a dedicated marketing strategy.
“This collaborative opportunity will help unite a ‘critical link’ in global Cold Chain Logistics and Biobanking for the life science community,” said A. Neil Jones, Vice President of Kryosphere.
Cryoport’s Chairman Stephen Wasserman stated, “Globalization of the life science and healthcare industries is driving increased demand for high quality frozen shipping and repository services. It is a natural fit for two industry leaders like Cryoport and Kryosphere to cooperate in providing the absolute best solutions for our respective customers. We look forward to working with the strong team at Kryosphere to make this alliance a success.”
About Kryosphere, Inc.
As a leading full-service Biomaterial Management Organization, Kryosphere combines the latest technology and scientific expertise in Biospecimen Sample Management, Clinical Trial Support and Cold Chain of Custody Logistics. Kryosphere is a GLP/GMP Regulatory compliant company focused on the management of biomaterials ranging from controlled ambient temperature through LN2. Headquartered in the Research Triangle Park of North Carolina with global operations, Kryosphere consistently delivers high quality collaborative support by providing critical resources that will help assure/ensure the integrity of research as well as the future of drug discovery and personalized medicine. For more information about Kryosphere visit: www.kryosphere.com.
About Cryoport, Inc.
Cryoport provides leading edge cold chain logistics services through the combination of purpose built proprietary technologies and total turnkey management of the entire process. The Cryoport Express® liquid nitrogen dry vapor shipper is validated to maintain a constant -150°C temperature for a 10 plus day dynamic shipment duration, and its Cryoportal™ Logistics Management Platform manages the entire shipment process, including initial order, document preparation, customs clearance, courier management, shipment tracking, issue resolution, and delivery. Cryoport’s total turnkey service management approach offers reliability, cost effectiveness, and convenience, while the use of recyclable and reusable components provides a “green” and environmentally friendly solution. For more information visit www.cryoport.com.
Forward Looking Statements
Statements in this press release which are not purely historical, including statements regarding Cryoport, Inc.’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. It is important to note that the company’s actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company’s cash flow, market acceptance risks, and technical development risks. The company’s business could be affected by a number of other factors, including the risk factors listed from time to time in the company’s SEC reports including, but not limited to, the annual report on Form 10-K for the year ended March 31, 2012. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Cryoport, Inc. disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
Please read our Full Disclaimer pertaining to this article.